Northrop Grumman Corporation director Mark A. Welsh III filed a Form 144 notice of proposed sale of 196 shares of common stock, with a notice date of November 2, 2026.
Victoria's Secret & Co. officer Melinda McAfee filed a Form 144 notice of proposed sale of 7,000 shares of common stock on November 2, 2026, listing NYSE as the exchange and Merrill Lynch as the executing broker.
Joby Aviation director Paul Sciarra filed a Form 144 notice on November 2, 2026, disclosing a proposed sale of 62,500 shares of Joby Aviation common stock with an aggregate market value of $310,898.56.
Castle Biosciences, Inc. officer Derek Maetzold filed a Form 144 notice of proposed sale of 21,438 shares of common stock, with an approximate sale date of November 2, 2026, through Goldman Sachs & Co. LLC.
Arthur J. Gallagher & Co. officer Douglas K. Howell filed a Form 144 notice of proposed sale of 3,000 shares of the company's common stock, with an approximate sale date of November 2, 2026, executed through Goldman Sachs & Co. LLC.
L3Harris Technologies, Inc. officer Christopher Kubasik filed a Form 144 notice on November 2, 2026, disclosing a proposed sale of 15,000 shares of common stock on the NYSE through Goldman Sachs and Co. LLC.
Director Joseph F. Hanna filed a Form 144 notice of proposed sale of 4,748 shares of McGrath RentCorp common stock on November 2, 2026, through Charles Schwab & Co., Inc., with an aggregate market value of $620,710.00.
Jeffrey P. Foster, an officer of CubeSmart, filed a Form 144 notice of proposed sale of 22,776 shares of common stock on November 2, 2026, following a stock option exercise on the same date.
Arcutis Biotherapeutics, Inc. officer Patrick Burnett filed a Form 144 notice of proposed sale of securities on November 2, 2026, disclosing plans to sell 943 shares of common stock on NASDAQ.
Kristine Syrvalin, an officer of Metallus Inc., filed a Form 144 notice of proposed sale of securities on November 2, 2026, covering 9,092 shares of common stock with an aggregate market value of $200,024.